Clinical trial
Efficacy of Non-invasive NESA Neuromodulation in Fibromyalgia: a Randomised, Triple-blind Clinical Trial
NCT05648695 is registered in ClinicalTrials.gov with University of Las Palmas de Gran Canaria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Non-invasive NESA Neuromodulation in Fibromyalgia: a Randomised, Triple-blind Clinical Trial
- Lead sponsor
- University of Las Palmas de Gran Canaria
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2022
- Completion date
- April 21, 2023
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.